A0A2J8S830 (A0A2J8S830_PONAB) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)
ELOB isoform 3 UniProtKBInterProInteractive Modelling
118 aa; Sequence (Fasta) ;
8 identical sequences: Homo sapiens: Q15370; Pan troglodytes: K7BP33, A0A6D2Y9A4; Papio anubis: A0A096NL81; Macaca mulatta: I2CTS0; Macaca fascicularis: A0A2K5UJD0; Rhinopithecus bieti: A0A2K6KJ09; Piliocolobus tephrosceles: A0A8C9I8I0
It is possible new templates exist for this target since these models were created.
Available Structures
106 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
SOCS box elonginBC ternary complex |
Heteromer O35718; P83940; Q15370; | |||||
Assess | ||||||
HIV-1 Vif SOCS-box and Elongin BC solution structure |
Heteromer P12504; Q15369; Q15370; | |||||
Assess | ||||||
Structural basis of Cullin-2 RING E3 ligase regulation by the COP9 signalosome |
Heteromer P40337; P61201; P62877; Q13098; Q13617; Q15369; Q15370; Q15843; Q7L5N1; Q92905; Q99627; Q9BT78; Q9H9Q2; Q9UNS2; | |||||
Assess | ||||||
Structure of a HIF-1a-pVHL-ElonginB-ElonginC Complex |
Heteromer P40337; Q15369; Q15370; Q16665; | |||||
Assess | ||||||
Crystal structure of HIF-2alpha-pVHL-elongin B-elongin C |
Heteromer P40337; Q15369; Q15370; Q99814; | |||||
Assess | ||||||
Structural basis of Cullin-2 RING E3 ligase regulation by the COP9 signalosome |
Heteromer P61201; P62877; Q03071; Q13098; Q13617; Q15370; Q15843; Q7L5N1; Q92905; Q99627; Q9BT78; Q9H9Q2; Q9UNS2; | 4×ZN; | ||||
Assess | ||||||
von Hippel-Lindau protein-ElonginB-ElonginC complex, bound to Hif1- alpha peptide |
Heteromer P40337; Q15369; Q15370; Q16665; | 1×GOL; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with (4-(1H-pyrrol-1-yl)phenyl)methanol |
Heteromer P40337; Q15369; Q15370; Q16665; | 1×SO4; 1×F4K; 1×GOL; | ||||
Assess | ||||||
Structure of pVHL-elongin B-elongin C (VCB) in complex with hydroxylated-HIF-2alpha (523-542) in th… |
Heteromer P40337; Q15370; Q2KII4; Q99814; | 1×GOL; | ||||
Assess | ||||||
PROTAC6 mediated complex of VHL:EloB:EloC and Bcl-xL |
Heteromer P40337; Q07817; Q15369; Q15370; | 1×QL8; 17×EDO; 9×GOL; 12×IOD; | ||||
Assess | ||||||
Ternary complex of VHL/BRD4-BD1/Compound9 (4-(3,5-difluoropyridin-2-yl)-N-(11-(((S)-1-((2S,4R)-4-hy… |
Heteromer O60885; P40337; Q15369; Q15370; | 1×WEP; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF SOCS-4 IN COMPLEX WITH ELONGIN-B AND ELONGIN-C AT 2.55A RESOLUTION |
Heteromer Q15369; Q15370; Q8WXH5; | 1×NA; 1×EDO; 1×CL; | ||||
Assess | ||||||
VHL recognizes hydroxyproline in RIPK1 |
Heteromer P40337; Q13546; Q15369; Q15370; | |||||
Assess | ||||||
pVHL-EloB-EloB-EloC complex_(2S,4R)-1-(2-chlorophenyl)carbonyl-N-[(4-chlorophenyl)methyl]-4-oxidany… |
Heteromer P40337; Q15369; Q15370; | 1×ACT; 1×UCK; | ||||
Assess | ||||||
Ankyrin repeat and SOCS-box protein 9 (ASB9), ElonginB (ELOB), and ElonginC (ELOC) bound to its sub… |
Heteromer P12277; Q15369; Q15370; Q96DX5; | |||||
Assess | ||||||
Crystal structure of compound 10 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC… |
Heteromer P40337; P51531; Q15369; Q15370; | 7×IOD; 1×IFJ; | ||||
Assess | ||||||
Ternary complex between VCB, BRD4-BD1 and PROTAC 48 |
Heteromer O60885; P40337; Q15369; Q15370; | 4×SO4; 6×EDO; 1×QIY; | ||||
Assess | ||||||
Crystal structure of PROTAC 2 in complex with the bromodomain of human SMARCA4 and pVHL:ElonginC:El… |
Heteromer P40337; P51532; Q15369; Q15370; | 1×FWZ; 1×DMS; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with modified HIF-1a CODD peptide containing (3R,4S)-3-fluoro-4-hydroxypr… |
Heteromer P40337; Q15369; Q15370; Q16665; | |||||
Assess | ||||||
Structure of pVHL-elongin B-elongin C (VCB) in complex with hydroxylated-HIF-2alpha (523-542) in th… |
Heteromer P40337; Q15369; Q15370; Q99814; | 1×FMT; | ||||
Assess | ||||||
Crystal structure of compound 6 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:… |
Heteromer P40337; P51531; Q15369; Q15370; | 1×IFF; | ||||
Assess | ||||||
Crystal structure of a hydroxylated HIF-1 alpha peptide bound to the pVHL/elongin-C/elongin-B compl… |
Heteromer P40337; Q15369; Q15370; Q16665; | 1×SO4; | ||||
Assess | ||||||
pVHL-ELOB-ELOC complex_(2S,4R)-1-(3-amino-2-methylbenzoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)ben… |
Heteromer P40337; Q15369; Q15370; | 1×TG0; | ||||
Assess | ||||||
VCB in complex with compound 30 |
Heteromer P40337; Q15369; Q15370; | 1×QE0; | ||||
Assess | ||||||
Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with PEG linker (conformation #2) |
Heteromer P40337; P61964; Q15369; Q15370; | 5×SCN; 1×Q3X; 7×EDO; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with (2S,4R)-4-hydroxy-1-((S)-2-(2-hydroxyacetamido)-3,3-dimethylbutanoyl… |
Heteromer P40337; Q15369; Q15370; | 1×9BT; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(cyclobutanecarboxamido)-3,3-dimethylbutanoyl)-4-hy… |
Heteromer P40337; Q15369; Q15370; | 1×9BH; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-y… |
Heteromer P40337; Q15369; Q15370; | 1×3JU; | ||||
Assess | ||||||
VCB in complex with compound 32 |
Heteromer P40337; Q15369; Q15370; | 1×QF7; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-fluorocyclopropanecarboxamido)-3,3-dimethylbutan… |
Heteromer P40337; Q15369; Q15370; | 1×4YY; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-3,3-dimethyl-2-(oxetane-3-carboxamido)butanoyl)-4-hyd… |
Heteromer P40337; Q15369; Q15370; | 1×9B8; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(cyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-h… |
Heteromer P40337; Q15369; Q15370; | 1×9BW; | ||||
Assess | ||||||
Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with Aryl linker |
Heteromer P40337; P61964; Q15369; Q15370; | 10×SCN; 1×Q43; 4×EDO; 1×K; | ||||
Assess | ||||||
Crystal structure of PROTAC 1 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:El… |
Heteromer P40337; P51531; Q15369; Q15370; | 1×FX8; 11×EDO; 1×FMT; | ||||
Assess | ||||||
Crystal structure of PROTAC 5 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:El… |
Heteromer P40337; P51531; Q15369; Q15370; | 1×IEI; | ||||
Assess | ||||||
Crystal Structure of ligand ACBi1 in complex with bromodomain of human Smarca2 and pVHL:ElonginC:El… |
Heteromer P40337; P51531; Q15369; Q15370; | 7×EDO; 4×NA; 2×PEG; 1×87A; | ||||
Assess | ||||||
VCB in complex with compound 27 |
Heteromer P40337; Q15369; Q15370; | 1×QF3; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-acetamidocyclopropanecarboxamido)-3,3-dimethylbu… |
Heteromer P40337; Q15369; Q15370; | 1×9BK; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with modified VH032 containing (3S,4S)-3-fluoro-4-hydroxyproline (ligand … |
Heteromer P40337; Q15369; Q15370; | 1×EXE; | ||||
Assess | ||||||
Crystal structure of pVHL:ElonginC:ElonginB complex bound to PROTAC JW48 |
Heteromer P40337; Q15369; Q15370; | 1×SYF; | ||||
Assess | ||||||
Crystal structure of PROTAC 2 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:El… |
Heteromer P40337; P51531; Q15369; Q15370; | 8×EDO; 1×FWZ; 1×EPE; | ||||
Assess | ||||||
von Hippel Lindau protein:ElonginB:ElonginC complex, in complex with (2S,4R)-N-methyl-1-[2-(3-methy… |
Heteromer P40337; Q15369; Q15370; | 1×QD0; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with VH298 |
Heteromer P40337; Q15369; Q15370; | 1×6Z3; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-Acetamidopropanethioyl)-4-hydroxy-N-(4-(4-methylthi… |
Heteromer P40337; Q15369; Q15370; | 1×DV5; | ||||
Assess | ||||||
Crystal Structure of Ankyrin Repeat and Socs Box-Containing Protein 9 (Asb9) in Complex with Elongi… |
Heteromer Q15369; Q15370; Q96DX5; | 1×EDO; 1×PEG; 1×CL; | ||||
Assess | ||||||
pVHL54-213-EloB-EloC complex _ (2S,4R)-N-((1,1'-biphenyl)-4-ylmethyl)- 4-hydroxy-1-(2-(3-methylisox… |
Heteromer P40337; Q15369; Q15370; | 1×TR0; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-acetylcyclopropanecarboxamido)-3,3-dimethylbutan… |
Heteromer P40337; Q15369; Q15370; | 1×9BN; | ||||
Assess | ||||||
The PROTAC MZ1 in complex with the second bromodomain of Brd4 and pVHL:ElonginC:ElonginB |
Heteromer O60885; P40337; Q15369; Q15370; | 1×759; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with modified VH032 containing (3R,4S)-3-fluoro-4-hydroxyproline (ligand … |
Heteromer P40337; Q15369; Q15370; | 1×EXH; | ||||
Assess | ||||||
Ternary complex between VCB, BRD4-BD2 and PROTAC 51 |
Heteromer O60885; P40337; Q15369; Q15370; | 1×QLX; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with N-((S)-1-((2S,4R)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carba… |
Heteromer P40337; Q15369; Q15370; | 1×DV8; | ||||
Assess | ||||||
VCB in complex with compound 23 |
Heteromer P40337; Q15369; Q15370; | 1×QFR; | ||||
Assess | ||||||
Crystal structure of SOCS2:Elongin C:Elongin B in complex with growth hormone receptor peptide |
Heteromer O14508; Q15369; Q15370; | 1×CO; | ||||
Assess | ||||||
Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with C3 linker |
Heteromer P40337; P61964; Q15369; Q15370; | 1×Q3R; | ||||
Assess | ||||||
VCB in complex with compound 21 |
Heteromer P40337; Q15369; Q15370; | 1×QFF; | ||||
Assess | ||||||
Ankyrin repeat and SOCS-box protein 9 (ASB9) in complex with ElonginB and ElonginC |
Heteromer Q15369; Q15370; Q96DX5; | 1×EDO; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-acetamidopropanoyl)-4-hydroxy-N-(4-(4-methylthiazol… |
Heteromer P40337; Q15369; Q15370; | 1×9B5; | ||||
Assess | ||||||
Ternary complex between VCB, BRD4-BD2 and PROTAC 48 |
Heteromer O60885; P40337; Q15369; Q15370; | 1×QIY; | ||||
Assess | ||||||
Ternary complex between VCB, BRD4-BD1 and PROTAC 49 |
Heteromer O60885; P40337; Q15369; Q15370; | 1×SO4; 1×QIK; | ||||
Assess | ||||||
Structure of VHL-EloB-EloC-Cul2 |
Heteromer P40337; Q13617; Q15369; Q15370; | |||||
Assess | ||||||
Crystal structure of macrocyclic PROTAC 1 in complex with the second bromodomain of human Brd4 and … |
Heteromer O60885; P40337; Q15369; Q15370; | 1×LFE; | ||||
Assess | ||||||
Structural basis of Cullin-2 RING E3 ligase regulation by the COP9 signalosome |
Heteromer P61201; P62877; Q13098; Q13617; Q15369; Q15370; Q7L5N1; Q92905; Q99627; Q9BT78; Q9H9Q2; Q9UNS2; | |||||
Assess | ||||||
Structural basis of Cullin-2 RING E3 ligase regulation by the COP9 signalosome |
Heteromer P40337; P61201; P62877; Q03071; Q13098; Q13617; Q15370; Q7L5N1; Q92905; Q99627; Q9BT78; Q9H9Q2; Q9UNS2; | 1×ZN; | ||||
Assess | ||||||
Structural basis of Cullin-2 RING E3 ligase regulation by the COP9 signalosome |
Heteromer P61201; P62877; Q13098; Q13617; Q15369; Q15370; Q99627; Q9BT78; Q9H9Q2; Q9UNS2; | 3×ZN; | ||||
Assess | ||||||
Crystal structure of Protac MS33 in complex with the WD repeat-containing protein 5 and pVHL:Elongi… |
Heteromer P40337; P61964; Q15369; Q15370; | 4×SCN; 5×EDO; 1×VKA; 1×GOL; 1×NA; | ||||
Assess | ||||||
Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with PEG linker (conformation #1) |
Heteromer P40337; P61964; Q15369; Q15370; | 15×SCN; 13×EDO; 1×P6G; 1×Q3X; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF SOCS-2 IN COMPLEX WITH ELONGIN-B AND ELONGIN-C AT 1.9A RESOLUTION |
Heteromer O14508; Q15369; Q15370; | 3×SO4; 3×NI; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with methyl 4H-furo[3,2-b]pyrrole-5-carboxylate |
Heteromer P40337; Q15369; Q15370; | 2×ACT; 1×F4E; | ||||
Assess | ||||||
Crystal structure of SOCS2:Elongin C:Elongin B in complex with growth hormone receptor peptide |
Heteromer O14508; Q15369; Q15370; | 1×CO; | ||||
Assess | ||||||
VCB in complex with compound 26 |
Heteromer P40337; Q15369; Q15370; | 1×QE9; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-acetamido-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-m… |
Heteromer P40337; Q15369; Q15370; | 1×3JF; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-3-phenylpropanamido)-3,3-dimethylb… |
Heteromer P40337; Q15369; Q15370; | 1×3JO; | ||||
Assess | ||||||
Crystal structure of Protac MS67 in complex with the WD repeat-containing protein 5 and pVHL:Elongi… |
Heteromer P40337; P61964; Q15369; Q15370; | 1×GOL; 1×X6M; | ||||
Assess | ||||||
von Hippel Lindau protein:ElonginB:ElonginC complex, in complex with (2S,4R)-1-ethanoyl-N-[[4-(1,3-… |
Heteromer P40337; Q15369; Q15370; | 1×X6C; 1×ACT; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methyloxazol-5-yl… |
Heteromer P40337; Q15369; Q15370; | 1×3JK; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(oxazol-5-yl)benzyl)… |
Heteromer P40337; Q15369; Q15370; | 1×3JG; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-4-methylpentanamido)-3,3-dimethylb… |
Heteromer P40337; Q15369; Q15370; | 1×3JH; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-3,3-dimethylbutanamido)-3,3-dimeth… |
Heteromer P40337; Q15369; Q15370; | 1×3JJ; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with (2S,4R)-1-((2S,4R)-1-acetyl-4-hydroxypyrrolidine-2-carbonyl)-4-hydro… |
Heteromer P40337; Q15369; Q15370; | 1×3JS; | ||||
Assess | ||||||
Quaternary Complex of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC Homer |
Heteromer P40337; P61964; Q15369; Q15370; | 1×8KH; | ||||
Assess | ||||||
pVHL:EloB:EloC complex, in complex with capped Hydroxyproline |
Heteromer P40337; Q15369; Q15370; | 3×ACT; 1×V6F; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with 6-chlorothiochroman-4-one |
Heteromer P40337; Q15369; Q15370; | 1×F7B; 1×IPA; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(thiazol-5-yl)benzyl… |
Heteromer P40337; Q15369; Q15370; | 1×3JT; | ||||
Assess | ||||||
Crystal structure of SOCS2:Elongin C:Elongin B in complex with erythropoietin receptor peptide |
Heteromer O14508; Q15369; Q15370; | 1×PEG; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(3-methyl-4-(thiazol-5-… |
Heteromer P40337; Q15369; Q15370; | 1×3JV; | ||||
Assess | ||||||
pVHL:EloB:EloC in complex with (4-(1H-pyrrol-1-yl)phenyl)methanol |
Heteromer P40337; Q15369; Q15370; | |||||
Assess | ||||||
pVHL54-213-EloB-EloC complex _ methyl 4-(((2S,4R)-4-hydroxy-1-(2-(3- methylisoxazol-5-yl)acetyl)pyr… |
Heteromer P40337; Q15369; Q15370; | 1×ZTD; | ||||
Assess | ||||||
pVHL54-213-EloB-EloC complex_apo |
Heteromer P40337; Q15369; Q15370; | |||||
Assess | ||||||
pVHL:EloB:EloC in complex with N-((S)-1-((2S,4R)-4-Hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carba… |
Heteromer P40337; Q15369; Q15370; | 1×DV2; | ||||
Assess | ||||||
Structure of SOCS2:Elongin C:Elongin B from DMSO-treated crystals |
Heteromer O14508; Q15369; Q15370; | |||||
Assess | ||||||
Crystal structure of SOCS2/ElonginB/ElonginC bound to a non-canonical peptide that enhances phospho… |
Heteromer O14508; Q15369; Q15370; | 1×SO4; | ||||
Assess | ||||||
pVHL54-213-EloB-EloC complex_(2S,4R)-4-hydroxy-1-(2-(3-methylisoxazol- 5-yl)acetyl)-N-(4-nitrobenzy… |
Heteromer P40337; Q15369; Q15370; | 1×GOL; 1×ZUN; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF AT7 IN COMPLEX WITH THE SECOND BROMODOMAIN OF HUMAN BRD4 AND PVHL:ELONGINC:ELO… |
Heteromer O60885; P40337; Q15369; Q15370; | 1×IZR; | ||||
Assess | ||||||
Crystal Structure of the HIV Vif BC-box in Complex with Human ElonginB and ElonginC |
Heteromer P12504; Q15369; Q15370; | |||||
Assess | ||||||
Crystal Structure of SOCS1 in complex with ElonginB and ElonginC |
Heteromer C0LEJ4; Q00560; Q15369; Q15370; | |||||
Assess | ||||||
Structure of KLHDC2-EloB/C tetrameric assembly |
Heteromer Q15369; Q15370; Q9Y2U9; | |||||
Assess | ||||||
pVHL54-213-EloB-EloC complex (4R)-4-HYDROXY-1-[(3-METHYLISOXAZOL-5-YL)ACETYL]-N-[4-(1,3-OXAZOL-5-YL… |
Heteromer P40337; Q15369; Q15370; | 1×L8B; | ||||
Assess | ||||||
THE VHL-ELONGINC-ELONGINB STRUCTURE |
Heteromer P40337; Q15369; Q15370; | |||||
Assess | ||||||
Crystal structure of SIVrcm Vif-CBFbeta-ELOB-ELOC complex |
Heteromer E1ANT9; Q13951; Q15369; Q15370; | 1×ZN; 1×GOL; | ||||
Assess | ||||||
Crystal structure of the Vif-CBFbeta-CUL5-ElOB-ElOC pentameric complex |
Heteromer P12504; Q13951; Q15369; Q15370; Q93034; | 1×ZN; | ||||
Assess | ||||||
Crystal structure of the Cul2-Rbx1-EloBC-VHL ubiquitin ligase complex |
Heteromer P40337; P62877; Q13617; Q15369; Q15370; | 3×ZN; | ||||
Assess | ||||||
H. sapiens replisome-CUL2/LRR1 complex |
Heteromer O75419; O75717; P25205; P33991; P33992; P33993; P49736; P56282; P62877; Q07864; Q13617; Q14566; Q14691; Q15369; Q15370; Q96L50; Q9BRT9; Q9BRX5; Q9BVW5; Q9HAW4; Q9UNS1; Q9Y248; | 9×ZN; 3×MG; 3×ANP; 1×SO4; | ||||
Assess | ||||||
Maedi visna virus Vif in complex with CypA and E3 ubiquitin ligase |
Heteromer P62937; P69717; Q15369; Q15370; | 2×ZN; | ||||
Assess | ||||||
Cryo-EM structure of human APOBEC3G/HIV-1 Vif/CBFbeta/ELOB/ELOC monomeric complex |
Heteromer Q13951; Q15369; Q15370; Q77YG0; Q9HC16; | 3×ZN; | ||||
Assess | ||||||
Cryo-EM structure of human APOBEC3G/HIV-1 Vif/CBFbeta/ELOB/ELOC dimeric complex in State 2 |
Heteromer Q13951; Q15369; Q15370; Q77YG0; Q9HC16; | 6×ZN; | ||||
Assess | ||||||
Cryo-EM structure of human APOBEC3G/HIV-1 Vif/CBFbeta/ELOB/ELOC dimeric complex in State 1 |
Heteromer Q13951; Q15369; Q15370; Q77YG0; Q9HC16; | 6×ZN; | ||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
3ztc.3.A | monomer | 0.76 | 100.00 | |||
Assess |